2020年8月12日，特朗普总统宣布我们已经与莫德纳（Moderna）公司达成协议，生产和交付1亿支由该公司生产的COVID-19候选疫苗！目前共有3种候选疫苗进入三期临床试验（试验的最后阶段）！

这支名为mRNA-1273的疫苗是由莫德纳公司和美国过敏与传染病研究所（NIAID）的科学家们共同开发。

莫德纳公司将在临床试验进行的同时开始生产疫苗，这样做缩短了传统疫苗的开发时间线，同时朝着美国政府的“曲速行动”目标迈进，即在年底前开始向美国人民提供安全有效的疫苗。如果这些疫苗被用在COVID-19疫苗接种行动中，则该疫苗将免费提供给美国人民。

更多内容：https://www.defense.gov/Newsroom/Releases/Release/Article/2309561/trump-administration-collaborates-with-moderna-to-produce-100-million-doses-of/

AP Images

On August 12, President Trump announced that we've reached an agreement with Moderna to manufacture and deliver 100 million doses of their COVID-19 vaccine candidate! There are now 3 vaccine candidates in Phase 3—the final stage of trials!

The vaccine, called mRNA-1273, has been co-developed by Moderna and scientists from the National Institute of Allergy and Infectious Diseases (NIAID).

Moderna will manufacture the vaccine doses while clinical trials are underway. Manufacturing in parallel with clinical trials expedites the traditional vaccine development timeline and builds toward the U.S. government’s Operation Warp Speed goal to begin delivering safe and effective vaccines to the American people by the end of the year. If these doses are used in a COVID-19 vaccination campaign, the vaccine would be available to the American people at no cost.

More info: https://www.defense.gov/Newsroom/Releases/Release/Article/2309561/trump-administration-collaborates-with-moderna-to-produce-100-million-doses-of/

出处：美国驻华大使馆（微信订阅号：USEmbassyChina）